Nothing Special   »   [go: up one dir, main page]

Mazzeo et al., 2009 - Google Patents

Stability studies for biologics

Mazzeo et al., 2009

Document ID
16780700473434347151
Author
Mazzeo A
Carpenter P
Publication year
Publication venue
Handbook of stability testing in pharmaceutical development: Regulations, methodologies, and best practices

External Links

Snippet

Biological products represent a growing segment of the pharmaceutical industry. Stability studies of these complex biologics present challenges beyond those found for the typical small-molecule pharmaceutical. Biologic products are typically only marginally stable, not …
Continue reading at link.springer.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/558—Immunoassay; Biospecific binding assay using diffusion or migration of antigen or antibody
    • G01N33/561—Immunoelectrophoresis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/543—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416—Systems
    • G01N27/447—Systems using electrophoresis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation

Similar Documents

Publication Publication Date Title
Hawe et al. Forced degradation of therapeutic proteins
Arora et al. Charge-mediated Fab-Fc interactions in an IgG1 antibody induce reversible self-association, cluster formation, and elevated viscosity
Razinkov et al. Accelerated formulation development of monoclonal antibodies (mAbs) and mAb-based modalities: review of methods and tools
Nail et al. Development and manufacture of protein pharmaceuticals
Arora et al. Hydrogen exchange mass spectrometry reveals protein interfaces and distant dynamic coupling effects during the reversible self-association of an IgG1 monoclonal antibody
Halley et al. An industry perspective on forced degradation studies of biopharmaceuticals: survey outcome and recommendations
Federici et al. Analytical lessons learned from selected therapeutic protein drug comparability studies
Jones et al. Complementary MS methods assist conformational characterization of antibodies with altered S–S bonding networks
Svilenov et al. The ReFOLD assay for protein formulation studies and prediction of protein aggregation during long-term storage
Rosa et al. Measuring and modeling hemoglobin aggregation below the freezing temperature
Moore-Kelly et al. Automated high-throughput capillary circular dichroism and intrinsic fluorescence spectroscopy for rapid determination of protein structure
Pritchard et al. The role of ion mobility spectrometry–mass spectrometry in the analysis of protein reference standards
Chen et al. Recent advancements in mass spectrometry for higher order structure characterization of protein therapeutics
Demarest et al. Differential scanning calorimetry in the biopharmaceutical sciences
Mazzeo et al. Stability studies for biologics
Dauer et al. High-throughput screening for colloidal stability of peptide formulations using dynamic and static light scattering
Gomes et al. In situ monitoring of protein unfolding/structural states under cold high-pressure stress
Hambly et al. Detection and quantitation of IgG 1 hinge aspartate isomerization: a rapid degradation in stressed stability studies
Davies et al. ICH Q5C stability testing of biotechnological/biological products
Hincal An introduction to safety issues in biosimilars/follow-on biopharmaceuticals
Meza et al. Predicting Colloidal Stability of High-Concentration Monoclonal Antibody Formulations in Common Pharmaceutical Buffers Using Improved Polyethylene Glycol Induced Protein Precipitation Assay
Ribeiro et al. Insights on the formulation of recombinant proteins
Razinkov et al. High-throughput formulation development of biopharmaceuticals: practical guide to methods and applications
Xin et al. Rapid Development of High Concentration Protein Formulation Driven by High-Throughput Technologies
Kulakova et al. Chemometrics in Protein Formulation: Stability Governed by Repulsion and Protein Unfolding